See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Baseball
Social Media
Natural Disasters
Donald Trump
Tariffs
Boxing
Soccer
Golf
Education
Artificial Intelligence
Immigration
Tennis
Published • loading... • Updated

Third Harmonic outlines plans for dissolution

Summary by biopharmadive.com
The Atlas-backed company plans to liquidate its assets, including an experimental drug for chronic spontaneous urticaria it pursued after halting work on a different immune drug in 2022.

1 Articles

All
Left
Center
1
Right
biopharmadive.combiopharmadive.com
Center

Third Harmonic outlines plans for dissolution

The Atlas-backed company plans to liquidate its assets, including an experimental drug for chronic spontaneous urticaria it pursued after halting work on a different immune drug in 2022.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

biopharmadive.com broke the news in on Monday, April 14, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal